Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections
María Guadalupe Martínez, Anders Boyd, Emmanuel Combe, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 3, pp. 706-717
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Hepatitis B
Wen‐Juei Jeng, George Papatheodoridis, Anna S. Lok
The Lancet (2023) Vol. 401, Iss. 10381, pp. 1039-1052
Closed Access | Times Cited: 289
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Grace Lai‐Hung Wong, Ed Gane, Anna S. Lok
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1249-1262
Open Access | Times Cited: 149
Interferon and Hepatitis B: Current and Future Perspectives
Jianyu Ye, Jieliang Chen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 129
The scientific basis of combination therapy for chronic hepatitis B functional cure
Seng Gee Lim, Thomas F. Baumert, Carolina Boni, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 4, pp. 238-253
Open Access | Times Cited: 93
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
Lena Allweiss, Barbara Testoni, Yu Mei, et al.
Gut (2023) Vol. 72, Iss. 5, pp. 972-983
Open Access | Times Cited: 44
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
New Perspectives on Development of Curative Strategies for Chronic Hepatitis B
Jordan J. Feld, Anna S. Lok, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2040-2050
Open Access | Times Cited: 31
HBx protein as a therapeutic target for functional cure of hepatitis B virus infection
Vijay Kumar
Virology (2025) Vol. 604, pp. 110438-110438
Closed Access | Times Cited: 1
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B
Barbara Testoni, Caroline Scholtès, Marie‐Laure Plissonnier, et al.
Gut (2023) Vol. 73, Iss. 4, pp. 659-667
Open Access | Times Cited: 22
Insights into the impact of hepatitis B virus on hepatic stellate cell activation
Hongjuan You, Xing Wang, Lihong Ma, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Eliminating cccDNA to cure hepatitis B virus infection
Fabien Zoulim, Barbara Testoni
Journal of Hepatology (2023) Vol. 78, Iss. 4, pp. 677-680
Open Access | Times Cited: 17
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
Edward Gane, Won Kim, Tien Huey Lim, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1139-1149
Closed Access | Times Cited: 17
An Overview of the Unfolded Protein Response (UPR) and Autophagy Pathways in Human Viral Oncogenesis
Shovan Dutta, Anirban Ganguly, Sounak Roy
International review of cell and molecular biology (2024), pp. 81-131
Closed Access | Times Cited: 6
The Hepatitis B Virus Nucleocapsid—Dynamic Compartment for Infectious Virus Production and New Antiviral Target
Matthias Niklasch, Peter Jan Zimmermann, Michael Nassal
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1577-1577
Open Access | Times Cited: 39
Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels
Tai‐Chung Tseng, Chieh Chiang, Chun‐Jen Liu, et al.
Gastroenterology (2023) Vol. 164, Iss. 4, pp. 669-679.e6
Closed Access | Times Cited: 16
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
Lili Liu, Hong Li, Yang Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13113-e13113
Open Access | Times Cited: 16
Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B
Harish Gopalakrishna, Marc G. Ghany
Current Hepatology Reports (2024) Vol. 23, Iss. 2, pp. 241-252
Open Access | Times Cited: 5
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes
Fleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 4, pp. 609-620
Open Access | Times Cited: 5
Gene Editing Technologies to Target HBV cccDNA
María Guadalupe Martínez, Elena M. Smekalova, Emmanuel Combe, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2654-2654
Open Access | Times Cited: 22
Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA
Elena S. Kim, Jun Zhou, Hu Zhang, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010576-e1010576
Open Access | Times Cited: 20
G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes
Guillaume Giraud, Mélanie Rodà, Pélagie Huchon, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 5, pp. 2290-2305
Open Access | Times Cited: 12
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo
Elena M. Smekalova, María Guadalupe Martínez, Emmanuel Combe, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 35, Iss. 1, pp. 102112-102112
Open Access | Times Cited: 12
An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
Liudi Tang, Stacy Remiszewski, Andrew Snedeker, et al.
Antiviral Research (2024) Vol. 226, pp. 105888-105888
Closed Access | Times Cited: 4
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
Jian Wang, Shaoqiu Zhang, Tao Fan, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Epigenetic Modifications in HBV‐Related Hepatocellular Carcinoma
Xiaoqing Tan, Linting Xun, Qi Yin, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top